Psychological and Psychiatric Treatment of Chronic Head and Face Pain

  • Taylor E. RushEmail author
  • Harold W. Goforth


Chronic head and facial pain is a multifaceted experience for patients, as it can pervasively affect the ability to function and ultimately hinder quality of life. Multidisciplinary approaches, including psychological and psychiatric interventions, for headache and facial pain are often necessary for successful treatment. Mood and anxiety symptoms, as well as deleterious health behaviors, can derail appropriate self-management, which then negatively affects medical management. This chapter will review cognitive-behavioral interventions, relaxation/biofeedback training, operant learning theory, the role of family support, and psychotropic medication options that can enhance health coping and effective head and facial pain management.


Cognitive-behavioral therapy Chronic pain Pain catastrophizing Pain interference Biofeedback Negative thought patterns Cognitive restructuring Relaxation techniques Sleep hygiene Psychotropic medications 


  1. 1.
    Hamelsky SW, Lipton RB. Psychiatric comorbidities of migraine. Headache. 2006;46:1327–33. Scholar
  2. 2.
    Harris P, Loveman E, Clegg A, et al. Systematic review of cognitive behavioral therapy for the management of headaches and migraines in adults. Br J Pain. 2015;9(4):213–24. Scholar
  3. 3.
    Ehde DM, Dillworth TM, Turner JA. Cognitive-behavioral therapy for individuals with chronic pain: efficacy, innovations, and directions for research. Am Psychol. 2014;69(2):153–66. Scholar
  4. 4.
    Moreira FP, Cardoso TA, Mondin TC, et al. The effect of proinflammatory cytokines in cognitive behavioral therapy. J Neuroimmunol. 2015;285:143–6.CrossRefPubMedGoogle Scholar
  5. 5.
    Quartana PJ, Campbell CM, Edwards RR. Pain catastrophizing: a critical review. Expert Rev Neurother. 2009;9(5):745–58. Scholar
  6. 6.
    Borkum JM. Maladaptive cognitions and chronic pain: epidemiology, neurobiology, and treatment. J Ration Emot Cogn Behav Ther. 2010;28:4–24. Scholar
  7. 7.
    Singh NN, Sahota P. Sleep-related headache and its management. Curr Treat Options Neurol. 2013;15:704–22. Scholar
  8. 8.
    Mitchell MD, Gehrman P, Umschied CA. Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review. BMC Fam Pract. 2012;13:40–51. CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Schramm SH, Moebus S, Lehmann N, et al. The association between stress and headache: a longitudinal population-based study. Cephalalgia. 2015;35(10):853–63. Scholar
  10. 10.
    Lipton RB, Buse DC, Hall CB, et al. Reduction in perceived stress as a migraine trigger: testing the “let-down headache” hypothesis. Neurology. 2014;82:1395–401.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    McGrady AV, Andrasik F, Davies T, et al. Psychophysiologic therapy for chronic headache in primary care. J Clin Psychiatry. 1999;1(4):96–102.Google Scholar
  12. 12.
    Rausa M, Palomba D, Cevoli S. Biofeedback in the prophylactic treatment of medication overuse headache: a pilot randomized controlled trial. J Headache Pain. 2016;17:87–95. Scholar
  13. 13.
    Fordyce WE. Behavioral methods for chronic pain and illness. St Louis: C.V. Mosby; 1976.Google Scholar
  14. 14.
    Gatzounis R, Schrooten MGS, Crombez G, et al. Operant learning theory in pain and chronic pain rehabilitation. Curr Pain Headache Rep. 2012;16:117–26. Scholar
  15. 15.
    Block AR, Kremer EF, Gaylor M. Behavioral treatment of chronic pain: the spouse as a discriminative cue for pain behavior. Pain. 1980;9:243–52.CrossRefPubMedGoogle Scholar
  16. 16.
    Kerns RD, Haythornwaithe J, Southwick S, et al. The role of marital interaction in chronic pain and depressive symptom severity. J Psychosom Res. 1990;34(4):401–8.CrossRefPubMedGoogle Scholar
  17. 17.
    Merikangas KR, Merikangas JR. Combination monoamine oxidase inhibitor and beta-blocker treatment of migraine, with anxiety and depression. Biol Psychiatry. 1995;38(9):603–10.CrossRefPubMedGoogle Scholar
  18. 18.
    Kuritzky A, Zoldan Y, Melamed E. MAO B inhibitor, is not effective in the prophylaxis of migraine without aura: an open study. Headache. 1992;32(8):416.CrossRefPubMedGoogle Scholar
  19. 19.
    Doyle Strauss L, Weizenbaum E, Loder EW, et al. Amitriptyline dose and treatment outcomes in specialty headache practice: a retrospective cohort study. Headache. 2016;56(10):1626–34.CrossRefPubMedGoogle Scholar
  20. 20.
    Linde M, Steiner TJ, Chisholm D. Cost-effectiveness analysis of interventions for migraine in four low- and middle-income countries. J Headache Pain. 2015;16:15.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Powers SW, Kashikar-Zuck SM, Allen JR. Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial. JAMA. 2013;310(24):2622–30.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Kalita J, Bhoi SK, Misra UK. Amitriptyline vs divalproate in migraine prophylaxis: a randomized controlled trial. Acta Neurol Scand. 2013;128(1):65–72.CrossRefPubMedGoogle Scholar
  23. 23.
    Pringsheim T, Davenport W, Mackie G, et al. Canadian Headache Society guideline for migraine prophylaxis. Can J Neurol Sci. 2012;39(2 Suppl 2):S1–59.PubMedGoogle Scholar
  24. 24.
    Krymchantowski AV, da Cunha Jevoux C, Bigal ME. Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders. J Headache Pain. 2012;13(1):53–9.CrossRefPubMedGoogle Scholar
  25. 25.
    Domingues RB, Silva AL, Domingues SA, et al. A double-blind randomized controlled trial of low doses of propranolol, nortriptyline, and the combination of propranolol and nortriptyline for the preventive treatment of migraine. Arq Neuropsiquiatr. 2009;67(4):973–7.CrossRefPubMedGoogle Scholar
  26. 26.
    Lampl C, Huber G, Adl J, Luthringshausen G, et al. Two different doses of amitriptyline ER in the prophylaxis of migraine: long-term results and predictive factors. Eur J Neurol. 2009;16(8):943–8.CrossRefPubMedGoogle Scholar
  27. 27.
    Moja PL, Cusi C, Sterzi RR, Canepari C. Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst Rev. 2005;20(3):CD002919.Google Scholar
  28. 28.
    Tarlaci S. Escitalopram and venlafaxine for the prophylaxis of migraine headache without mood disorders. Clin Neuropharmacol. 2009;32(5):254–8.CrossRefPubMedGoogle Scholar
  29. 29.
    Adly C, Straumanis J, Chesson A. Fluoxetine prophylaxis of migraine. Headache. 1992;32(2):101–4.CrossRefPubMedGoogle Scholar
  30. 30.
    Saper JR, Silberstein SD, Lake AE, et al. Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache. 1994;34(9):497–502.CrossRefPubMedGoogle Scholar
  31. 31.
    Bulut S, Berilgen MS, Baran A, et al. Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study. Clin Neurol Neurosurg. 2004;107(1):44–8.CrossRefPubMedGoogle Scholar
  32. 32.
    Young WB, Bradley KC, Anjum MW, et al. Duloxetine prophylaxis for episodic migraine in persons without depression: a prospective study. Headache. 2013;53(9):1430–7.PubMedGoogle Scholar
  33. 33.
    Volpe FM. An 8-week, open-label trial of duloxetine for comorbid major depressive disorder and chronic headache. J Clin Psychiatry. 2008;69(9):1449–54.CrossRefPubMedGoogle Scholar
  34. 34.
    Autret A, Valade D, Debiais S. Placebo and other psychological interactions in headache treatment. J Headache Pain. 2012;13:191–8. Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Center for Neurological Restoration, Neurological Institute, Cleveland ClinicClevelandUSA
  2. 2.Lerner College of Medicine, Cleveland Clinic Foundation, Center for Neurological Restoration, Section of Headache MedicineClevelandUSA

Personalised recommendations